|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.75 USD | +2.07% |
|
+3.13% | +11.96% |
| 06-30 | Zai Lab Insider Sold Shares Worth $428,545, According to a Recent SEC Filing | MT |
| 06-16 | Zai Lab Receives EU Orphan Drug Designation for Lung Cancer Drug | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 2.22B | - | ||||
| 67.44B | |||||
| 53.98B | |||||
| 41.77B | |||||
| 41.15B | - | ||||
| 29.28B | - |
- Stock Market
- Stocks
- ZLAB Stock
- Charts Zai Lab Limited
- Sector Chart
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
